Literature DB >> 21099244

Biliverdin reductase A in the prevention of cellular senescence against oxidative stress.

Sung Young Kim1, Hyun Tae Kang, Hae Ri Choi, Sang Chul Park.   

Abstract

Biliverdin reductase A (BLVRA), an enzyme that converts biliverdin to bilirubin, has recently emerged as a key regulator of the cellular redox cycle. However, the role of BLVRA in the aging process remains unclear. To study the role of BLVRA in the aging process, we compared the stress responses of young and senescent human diploid fibroblasts (HDFs) to the reactive oxygen species (ROS) inducer, hydrogen peroxide (H2O2). H2O2 markedly induced BLVRA activity in young HDFs, but not in senescent HDFs. Additionally, depletion of BLVRA reduced the H2O2-dependent induction of heme oxygenase-1 (HO-1) in young HDFs, but not in senescent cells, suggesting an aging-dependent differential modulation of responses to oxidative stress. The role of BLVRA in the regulation of cellular senescence was confirmed when lentiviral RNAi- transfected stable primary HDFs with reduced BLVRA expression showed upregulation of the CDK inhibitor family members p16, p53, and p21, followed by cell cycle arrest in G0-G1 phase with high expression of senescence-associated β-galactosidase. Taken together, these data support the notion that BLVRA contributes significantly to modulation of the aging process by adjusting the cellular oxidative status.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21099244      PMCID: PMC3041934          DOI: 10.3858/emm.2011.43.1.002

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  54 in total

1.  Age-related decline in expression of calnexin.

Authors:  Bok-Hee Choi; Jong-Suk Kim
Journal:  Exp Mol Med       Date:  2004-10-31       Impact factor: 8.718

Review 2.  Cellular senescence: when bad things happen to good cells.

Authors:  Judith Campisi; Fabrizio d'Adda di Fagagna
Journal:  Nat Rev Mol Cell Biol       Date:  2007-09       Impact factor: 94.444

Review 3.  Cellular senescence and cancer treatment.

Authors:  Clemens A Schmitt
Journal:  Biochim Biophys Acta       Date:  2006-08-25

4.  Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity.

Authors:  Nicole Lerner-Marmarosh; Jenny Shen; Michael D Torno; Anatoliy Kravets; Zhenbo Hu; Mahin D Maines
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

5.  ''Iatrogenic Gilbert syndrome''--a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin.

Authors:  Mark F McCarty
Journal:  Med Hypotheses       Date:  2007-09-06       Impact factor: 1.538

6.  Involvement of JNKs and p38-MAPK/MSK1 pathways in H2O2-induced upregulation of heme oxygenase-1 mRNA in H9c2 cells.

Authors:  Ioanna-Katerina S Aggeli; Catherine Gaitanaki; Isidoros Beis
Journal:  Cell Signal       Date:  2006-10       Impact factor: 4.315

7.  Bilirubin and glutathione have complementary antioxidant and cytoprotective roles.

Authors:  Thomas W Sedlak; Masoumeh Saleh; Daniel S Higginson; Bindu D Paul; Krishna R Juluri; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-13       Impact factor: 11.205

Review 8.  Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance.

Authors:  Urszula M Florczyk; Alicja Jozkowicz; Jozef Dulak
Journal:  Pharmacol Rep       Date:  2008 Jan-Feb       Impact factor: 3.024

9.  Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin.

Authors:  Cicerone Tudor; Nicole Lerner-Marmarosh; Yves Engelborghs; Peter E M Gibbs; Mahin D Maines
Journal:  Biochem J       Date:  2008-08-01       Impact factor: 3.857

10.  Old biliverdin reductase: links to insulin resistance and may be a novel therapeutic target.

Authors:  Bin Wu; Xiaoyan Liu; Jinfang Shen
Journal:  Med Hypotheses       Date:  2008-04-21       Impact factor: 1.538

View more
  17 in total

1.  Molecular modeling to provide insight into the substrate binding and catalytic mechanism of human biliverdin-IXα reductase.

Authors:  Gang Fu; Haining Liu; Robert J Doerksen
Journal:  J Phys Chem B       Date:  2012-08-07       Impact factor: 2.991

Review 2.  Senescence suppressors: their practical importance in replicative lifespan extension in stem cells.

Authors:  Eun Seong Hwang
Journal:  Cell Mol Life Sci       Date:  2014-07-23       Impact factor: 9.261

3.  Guiqi polysaccharide protects the normal human fetal lung fibroblast WI-38 cells from H2O2-induced premature senescence.

Authors:  Xiuying Pu; Shuang Yu; Wenbo Fan; Lu Liu; Xiaolong Ma; Jing Ren
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Molecular mechanisms of bilirubin induced G1 cell cycle arrest and apoptosis in human breast cancer cell lines: involvement of the intrinsic pathway.

Authors:  Seyedeh Zahra Shahrokhi; Fatemeh Soghra Karami Tehrani; Siamak Salami
Journal:  Mol Biol Rep       Date:  2022-09-14       Impact factor: 2.742

5.  Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.

Authors:  Makini K Cobourne-Duval; Equar Taka; Patricia Mendonca; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2018-05-04       Impact factor: 3.478

Review 6.  Heme Oxygenase 1 as a Therapeutic Target in Acute Kidney Injury.

Authors:  Subhashini Bolisetty; Abolfazl Zarjou; Anupam Agarwal
Journal:  Am J Kidney Dis       Date:  2017-01-27       Impact factor: 8.860

7.  Go green: the anti-inflammatory effects of biliverdin reductase.

Authors:  Barbara Wegiel; Leo E Otterbein
Journal:  Front Pharmacol       Date:  2012-03-16       Impact factor: 5.810

8.  Physiological antioxidative network of the bilirubin system in aging and age-related diseases.

Authors:  Sung Young Kim; Sang Chul Park
Journal:  Front Pharmacol       Date:  2012-03-14       Impact factor: 5.810

9.  Direct Antioxidant Properties of Bilirubin and Biliverdin. Is there a Role for Biliverdin Reductase?

Authors:  Thomas Jansen; Andreas Daiber
Journal:  Front Pharmacol       Date:  2012-03-16       Impact factor: 5.810

10.  Apoptosis induction of U937 human leukemia cells by diallyl trisulfide induces through generation of reactive oxygen species.

Authors:  Yung Hyun Choi; Hyun Soo Park
Journal:  J Biomed Sci       Date:  2012-05-11       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.